Comparative Double-Blind Trial of dl-α-Tocopheryl Nicotinate on Vibration Disease

Sixty inpatients with vibration disease were examined on the effect of dl-α-tocopheryl nicotinate by comparative double-blind study. The observed period was 6 weeks and the dose was 6 capsules a day (600 mg as dl-α-tocopheryl nicotinate, Juvela Nicotinate®, referred to as EN). The physical exercise therapy was applied to all patients throughout the test period. EN group became better with a significant difference from P (placebo) group in the subjective symptoms, the clinical examinations and the collective improving rate (p